Article
Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.
Journal of hematotherapy & stem cell research - 1 Aug 2003
Davis Brian M, Reese Jane S, Lingas Karen, Gerson Stanton L
Abstract excerpt
Optimized hematopoietic gene therapy requires vectors with strong expression in the desired target cell population and the ability to select for the expressing transduced cells. In the context of drug resistance selection of repopulating hematopoietic stem cells in the mouse, we examined tissue expression after transduced marrow transplantation of the drug selection gene, G156A mutant O6-methylguanine-DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
